논문KCI 등재
A dilemma that probably would never resolve
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (5)
- Sujata Lall, "The dilemma of differentiating between acute hepatitis B and chronic hepatitis B with acute exacerbation: Is quantitative serology the answer?", Clinical and Molecular Hepatology, 26(2), pp.187~195 (2020), 대한간학회
- Thanage R, "Factors differentiating acute hepatitis B from acute exacerbation of chronic hepatitis B in prospective-retrospective cohort", J Assoc Physicians India, 67, pp.39~43 (2019)
- Kumar M, "Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B", Dig Dis Sci, 51, pp.594~599 (2006)
- Park JW, "Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients", World J Gastroenterol, 21, pp.3953~3959 (2015)
- Gayno S, "Detection of serum HBV-DNA by polymerase chain reaction (PCR) in patients before reactivation of chronic hepatitis B", J Hepatol, 14, pp.357~360 (1992)
관련 논문AI추천
Can’t and Won’t김태일대한치주과학회 · Journal of Periodontal & Implant Science2014 · 제44권 제2호It is not Necessarily Bad장선미사단법인 한국언어학회 · 언어학2005 · 제13권 제1호The Trouble with CharactersCatherine Gallagher한국근대영미소설학회 · 근대영미소설2002 · 제9권 제2호Adding to the confusion in more than just the nameJacob George대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제4호At the Edge of the Breaking Point박준형한국학중앙연구원 · The Review of Korean Studies2018 · 제21권 제2호Conflict of Interest김수영대한가정의학회 · Korean Journal of Family Medicine2012 · 제33권 제3호
이 간행물의 다른 논문 (23건)
Current understanding of primary biliary cholangitisAtsushi Tanakapp. 1-21The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver diseaseChristopher D. Byrne, Erica Jennisonpp. 22-43Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspectiveAileen Wee, Gwyneth Soonpp. 44-57Recent updates on the management of autoimmune hepatitisAtsumasa Komoripp. 58-69The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the futureAtsunori Tsuchiya, Yusuke Watanabe, Shuji Teraipp. 70-80
